Market Overview

24 Stocks Moving in Friday's Pre-Market Session

Share:

Gainers

  • Mer Telemanagement Solutions Ltd. (NASDAQ: MTSL) rose 73.3% to $2.08 in pre-market trading after reporting half-year results. Mer Telemanagement reported H1'19 EPS of $(0.04) on sales of $2.6 million.
  • Fibrocell Science, Inc. (NASDAQ: FCSC) shares rose 60.1% to $2.93 in pre-market trading after the company agreed to be acquired by Castle Creek Pharmaceutical for an all-cash consideration of $3 per share.
  • DPW Holdings, Inc. (NYSE: DPW) shares rose 12.2% to $3.30 in pre-market trading after falling 7.26% on Thursday.
  • Akari Therapeutics, Plc (NASDAQ: AKTX) rose 11.8% to $2.18 in pre-market trading.
  • Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) shares rose 11.4% to $6.83 in pre-market trading after the news emerged that the company will not proceed with the previously announced public offering.
  • Seadrill Limited (NYSE: SDRL) rose 7.5% to $3.31 in pre-market trading after dropping 12.00% on Thursday.
  • Innovative Industrial Properties, Inc (NYSE: IIPR) rose 6% to $93.69 in pre-market trading after the company declared a third quarter 2019 dividend of $0.78 per share of common stock.
  • Evolent Health, Inc. (NYSE: EVH) rose 5.8% to $7.43 in pre-market trading after dropping 11.03% on Thursday.
  • Precipio, Inc. (NASDAQ: PRPO) rose 5.3% to $2.60 in pre-market trading.
  • Denali Therapeutics Inc. (NASDAQ: DNLI) rose 5% to $20.00 in pre-market trading after falling 3.00% on Thursday.
  • Barclays PLC (NYSE: BCS) rose 4.6% to $7.70 in pre-market trading.
  • MoSys Inc. (NASDAQ: MOSY) rose 4.4% to $2.62 in pre-market trading after the company announced it has regained compliance with NASDAQ's bid price listing requirements.
  • Aimmune Therapeutics, Inc. (NASDAQ: AIMT) rose 4.3% to $25.74 in pre-market trading.
  • Celyad SA (NASDAQ: CYAD) rose 4.2% to $10.42 in pre-market trading after declining 18.77% on Thursday.
  • Lloyds Banking Group plc (NYSE: LYG) rose 4% to $2.65 in pre-market trading.
  • Frontline Ltd. (NYSE: FRO) rose 3.3% to $9.01 in pre-market trading after the company reported the purchase of 10 Suezmax Tankers, 2 separate options to buy 2 plus 2 added tankers from Trafigura Maritime. BTIG upgraded Frontline from Neutral to Buy.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Ritter Pharmaceuticals Inc (NASDAQ: RTTR) shares fell 75% to $0.27 in pre-market trading after the company's Phase 3 trial of RP-G28 for lactose intolerance failed to demonstrate statistical significance in its pre-specified endpoint.
  • Ardelyx, Inc. (NASDAQ: ARDX) shares fell 18.8% to $5.10 in pre-market trading. Ardelyx announced the FDA has approved its tenapanor, brand name Ibsrela, a 50mg twice-daily oral pill for the treatment of irritable bowel syndrome with constipation in adults. The drug acts locally in the gastrointestinal tract by inhibiting the sodium-hydrogen exchanger, leading to increased bowel movements and decreased abdominal pain.
  • Contango Oil & Gas Company (NYSE: MCF) fell 7.5% to $0.92 in pre-market trading. Contango Oil & Gas priced 44.7 million share offering for gross proceeds of $42.5 million.
  • Yuma Energy, Inc. (NYSE: YUMA) shares fell 5.1% to $3.00 in pre-market trading after gaining 6.63% on Thursday.
  • Nutanix, Inc. (NASDAQ: NTNX) shares fell 4.5% to $25.53 in pre-market trading.
  • Safe-T Group Ltd (NASDAQ: SFET) shares fell 4.2% to $0.75 in pre-market trading after the company showed the registration for ~17.86 million ADS offering via selling shareholders.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) shares fell 4% to $2.89 in pre-market trading after rising 15.33% on Thursday.
  • Pembina Pipeline Corporation (NYSE: PBA) fell 2.5% to $36.00 in pre-market trading.

Posted-In: Premarket MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

 

Related Articles (AIMT + AKTX)

View Comments and Join the Discussion!

5 Best Ways To Use Your Credit Card Rewards

Catalyst Pharma Shares Pop After Cancelling Public Offering